These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38497174)
1. LncRNA FOXD3-AS1 Contributes to Glioblastoma Progression Via Sponging miR-3918 to Upregulate CCND1. Huang C; Shao T; Duan F; Li R; Luo M; Huang Q; Wang Y; Luo Z Turk Neurosurg; 2024; 34(2):224-234. PubMed ID: 38497174 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation. Hu J; Pan J; Luo Z; Duan Q; Wang D Cancer Gene Ther; 2021 Jun; 28(6):602-618. PubMed ID: 33204001 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p. Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis Zhang D; Lee H; Haspel JA; Jin Y FASEB J; 2017 Oct; 31(10):4472-4481. PubMed ID: 28655711 [TBL] [Abstract][Full Text] [Related]
5. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis. Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603 [TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung Adenocarcinoma. Xue Y; Diao M; Lyu J; Li K; He L; Chen J; Li X Cancer Biother Radiopharm; 2024 Oct; 39(8):573-583. PubMed ID: 34767727 [No Abstract] [Full Text] [Related]
7. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6. Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943 [TBL] [Abstract][Full Text] [Related]
8. Wan N; Yang W; Cheng H; Wang J Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225 [No Abstract] [Full Text] [Related]
9. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Chen Y; Gao H; Li Y Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422 [TBL] [Abstract][Full Text] [Related]
10. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766 [TBL] [Abstract][Full Text] [Related]
11. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2. Chen X; Gao J; Yu Y; Zhao Z; Pan Y Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886 [TBL] [Abstract][Full Text] [Related]
12. m Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K Cells; 2022 Sep; 11(19):. PubMed ID: 36230970 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis. Yan F; Ma Y; Liu L; Li L; Deng J; Sun J J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404 [TBL] [Abstract][Full Text] [Related]
14. LncRNA FOXD3-AS1 aggravates myocardial ischemia/reperfusion injury by inactivating the Redd1/AKT/GSK3β/Nrf2 signaling pathway via the miR-128/TXNIP axis. Chen B; Zheng L; Zhu T; Jiao K J Biochem Mol Toxicol; 2022 Dec; 36(12):e23218. PubMed ID: 36098178 [TBL] [Abstract][Full Text] [Related]
15. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR. Liu C; Zhang M; Zhao J; Zhu X; Zhu L; Yan M; Zhang X; Zhang R Cancer Biother Radiopharm; 2020 May; 35(4):292-300. PubMed ID: 32191537 [No Abstract] [Full Text] [Related]
16. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression. Cao L; Wang Y; Wang Q; Huang J Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q; Zhang W; Wang Z; Liu S BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis. Ling Z; Zhang J; Liu Q Bioengineered; 2022 Mar; 13(3):6012-6023. PubMed ID: 35191808 [TBL] [Abstract][Full Text] [Related]
19. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway. Ma WG; Shi SM; Chen L; Lou G; Feng XL J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937 [TBL] [Abstract][Full Text] [Related]
20. MicorRNA-195 links long non-coding RNA SEMA3B antisense RNA 1 (head to head) and cyclin D1 to regulate the proliferation of glioblastoma cells. Liu K; Deng Y; Yang Y; Wang H; Zhou P Bioengineered; 2022 Apr; 13(4):8798-8805. PubMed ID: 35287551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]